Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v3-EN
Language English English
Date Updated 2019-09-18 2019-09-18
Drug Identification Number 02408104 02408104
Brand name MYLAN-BUPRENORPHINE/NALOXONE MYLAN-BUPRENORPHINE/NALOXONE
Common or Proper name BUPRENORPHINE/NALOXONE BUPRENORPHINE/NALOXONE
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients BUPRENORPHINE NALOXONE BUPRENORPHINE NALOXONE
Strength(s) 8MG 2MG 8MG 2MG
Dosage form(s) TABLET TABLET
Route of administration SUBLINGUAL SUBLINGUAL
Packaging size 100BT 100BT
ATC code N07BC N07BC
ATC description DRUGS USED IN ADDICTIVE DISORDERS DRUGS USED IN ADDICTIVE DISORDERS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2019-09-17 2019-09-17
Actual discontinuation date 2019-09-17 2019-09-17
Remaining supply date 2019-09-17 2019-09-17
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Discontinued in Shortage ID 3089. Last lot 3085363 exp 2019-05-31 Discontinued in Shortage ID 3089. Last lot 3085363 exp 2019-05-31
Health Canada comments